This Day On The Street
Continue to site
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here

GenMark Diagnostics Inc (GNMK)

NASDAQ: Health Care

Company Income Statement
Dec 2015 Dec 2014 Dec 2013 Dec 2012
Sales 39.41M 30.59M 27.40M 20.47M
Cost of Sales 11.45M 9.77M 13.05M 10.44M
Gross Operating Profit 27.96M 20.82M 14.35M 10.03M
Selling, General, and Administrative Expenses 28.16M 24.70M 24.33M 17.18M
Research & Development 37.47M 31.82M 22.06M 13.54M
Operating Income before D & A (EBITDA) -37.66M -35.70M -32.04M -20.69M
Depreciation & Amortization 3.87M 3.36M 2.84M 1.20M
Interest Income 125.00K 244.00K 717.00K 0.00
Other Income - Net 133.00K -6.00K 583.00K -15.00K
Special Income / Charges 0.00 0.00 0.00 0.00
Total Income Before Interest Expenses (EBIT) -41.28M -38.82M -33.58M -21.91M
Interest Expense 880.00K 20.00K 19.00K 49.00K
Pre-Tax Income -42.16M -38.84M -33.60M -21.95M
Income Taxes 40.00K -573.00K 44.00K 148.00K
Minority Interest 0.00 0.00 0.00 0.00
Net Income From Continuing Operations -42.20M -38.26M -33.64M -22.10M
Net Income From Discontinued Operations 0.00 0.00 0.00 0.00
Net Income From Total Operations -42.20M -38.26M -33.64M -22.10M
Extraordinary Income/Losses 0.00 0.00 0.00 0.00
Income From Cum. Effect of Acct. Change 0.00 0.00 0.00 0.00
Income From Tax Loss Carryforward 0.00 0.00 0.00 0.00
Other Gains / Losses 0.00 0.00 0.00 0.00
Total Net Income -42.20M -38.26M -33.64M -22.10M
Normalized Income
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-42.20M -38.26M -33.64M -22.10M
Preferred Dividends
Net Income Available To Common -42.20M -38.26M -33.64M -22.10M
Basic EPS from Continuing Ops. -1.00 -0.93 -0.95 -0.84
Basic EPS from Discontinued Ops. 0.00 0.00 0.00 0.00
Basic EPS from Total Operations -1.00 -0.93 -0.95 -0.84
Basic EPS from Extraordinary Inc. 0.00 0.00 0.00 0.00
Basic EPS from Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
Basic EPS from Tax Loss Carryf'd. 0.00 0.00 0.00 0.00
Basic EPS from Other Gains (Losses) 0.00 0.00 0.00 0.00
Basic EPS, Total -1.00 -0.93 -0.95 -0.84
Basic Normalized Net Income/Share -1.00 -0.93 -0.95 -0.84
EPS fr Continuing Ops. -1.00 -0.93 -0.95 -0.84
EPS fr Discontinued Ops 0.00 0.00 0.00 0.00
EPS fr Total Ops. -1.00 -0.93 -0.95 -0.84
EPS fr Extraord. Inc. 0.00 0.00 0.00 0.00
EPS fr Cum Effect of Accounting Change 0.00 0.00 0.00 0.00
EPS fr Tax Loss Carfd. 0.00 0.00 0.00 0.00
EPS fr Other Gains (L) 0.00 0.00 0.00 0.00
EPS, Total -1.00 -0.93 -0.95 -0.84
Diluted Normalized Net Inc/Shr
(Net Income From Continuing Operations,
Ex. Special Income / Charge)
-1.00 -0.93 -0.95 -0.84
Dividends Paid per Share 0.00 0.00 0.00 0.00
GNMK News

Check Out Our Best Services for Investors

Action Alerts PLUS

Portfolio Manager Jim Cramer and Director of Research Jack Mohr reveal their investment tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
Quant Ratings

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
Stocks Under $10

David Peltier uncovers low dollar stocks with serious upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
14-Days Free
Only $9.95
14-Days Free
Dividend Stock Advisor

David Peltier identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Updates with exact steps to take - BUY, HOLD, SELL
Trifecta Stocks

Every recommendation goes through 3 layers of intense scrutiny—quantitative, fundamental and technical analysis—to maximize profit potential and minimize risk.

Product Features:
  • Model Portfolio
  • Intra Day Trade alerts
  • Access to Quant Ratings
Real Money

More than 30 investing pros with skin in the game give you actionable insight and investment ideas.

Product Features:
  • Access to Jim Cramer's daily blog
  • Intraday commentary and news
  • Real-time trading forums
Only $49.95
14-Days Free
14-Days Free

GNMK GenMark Diagnostics Inc

Chart of GNMK

Analysts Ratings for GNMK

Rating Current 1-Mo Ago 2-Mo Ago 3-Mo Ago
Strong Buy 4 4 4 3
Moderate Buy 1 1 1 2
Hold 1 1 1 1
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
GET GNMK ANALYST REPORT

GNMK Chatter

Top Rated Stocks Top Rated Funds Top Rated ETFs